Christopher Viehbacher, ex-CEO of Sanofi, has been appointed as the managing partner of Waypoint Capital's US-based fund, Gurnet Point Capital. Waypoint is the investment vehicle of the Bertarelli family, former owners of Serono, which was sold to Merck KGaA of Germany in 2007 in a deal worth around €10bn. Waypoint's chairman is Ernesto Bertarelli, the former CEO of Serono.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?